Meilian Zhuo

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Charles J. David · 3 shared papers, 2021–2026 · strength 0.61
   • Paper Protocol to package and concentrate adeno-associated virus serotype 8 for use in autochthonous mouse models of pancreat… DOI 10.1016/j.xpro.2023.102108↗
   • Paper A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma. DOI 10.1016/j.ccell.2026.03.021↗
   • Paper Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate… DOI 10.1038/s43018-020-00134-z↗
2. Mo Chen · 2 shared papers, 2021–2026 · strength 0.30
   • Paper A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma. DOI 10.1016/j.ccell.2026.03.021↗
   • Paper Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate… DOI 10.1038/s43018-020-00134-z↗
3. Junya Peng · 2 shared papers, 2021–2026 · strength 0.30
   • Paper A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma. DOI 10.1016/j.ccell.2026.03.021↗
   • Paper Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate… DOI 10.1038/s43018-020-00134-z↗
4. Yupei Zhao · 2 shared papers, 2021–2026 · strength 0.30
   • Paper A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma. DOI 10.1016/j.ccell.2026.03.021↗
   • Paper Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate… DOI 10.1038/s43018-020-00134-z↗
5. Xianlin Han · 1 shared paper, 2026 · strength 0.21
   • Paper A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma. DOI 10.1016/j.ccell.2026.03.021↗
6. Ruizhe He · 1 shared paper, 2026 · strength 0.21
   • Paper A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma. DOI 10.1016/j.ccell.2026.03.021↗
7. Mingyang Liu · 1 shared paper, 2026 · strength 0.21
   • Paper A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma. DOI 10.1016/j.ccell.2026.03.021↗
8. Menghua Dai · 1 shared paper, 2026 · strength 0.21
   • Paper A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma. DOI 10.1016/j.ccell.2026.03.021↗
9. Weibin Wang · 1 shared paper, 2026 · strength 0.21
   • Paper A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma. DOI 10.1016/j.ccell.2026.03.021↗
10. Yong Li · 1 shared paper, 2021 · strength 0.10
    • Paper Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate… DOI 10.1038/s43018-020-00134-z↗
11. Xun Lan · 1 shared paper, 2021 · strength 0.10
    • Paper Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate… DOI 10.1038/s43018-020-00134-z↗
12. Wenze Wang · 1 shared paper, 2021 · strength 0.10
    • Paper Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate… DOI 10.1038/s43018-020-00134-z↗
13. Wenming Wu · 1 shared paper, 2021 · strength 0.10
    • Paper Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate… DOI 10.1038/s43018-020-00134-z↗
14. Jing Xue · 1 shared paper, 2021 · strength 0.10
    • Paper Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate… DOI 10.1038/s43018-020-00134-z↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.